<DOC>
	<DOC>NCT01195688</DOC>
	<brief_summary>The primary objective of the current study is to investigate the safety and tolerability of BI 638683 in healthy male volunteers following oral administration of single rising doses</brief_summary>
	<brief_title>Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Inclusion criteria: healthy male subjects</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>